Lan Xu

7.0k total citations · 3 hit papers
38 papers, 5.9k citations indexed

About

Lan Xu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Lan Xu has authored 38 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Lan Xu's work include TGF-β signaling in diseases (11 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Nuclear Structure and Function (5 papers). Lan Xu is often cited by papers focused on TGF-β signaling in diseases (11 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Nuclear Structure and Function (5 papers). Lan Xu collaborates with scholars based in United States, China and India. Lan Xu's co-authors include Christopher K. Glass, Michael G. Rosenfeld, David W. Rose, Joan Massagué, Riki Kurokawa, Joseph Torchia, Thorsten Heinzel, Bernd Gloss, Sheng‐Cai Lin and Yasutomi Kamei and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Lan Xu

36 papers receiving 5.8k citations

Hit Papers

A CBP Integrator Complex Mediates Transcriptional Activat... 1996 2026 2006 2016 1996 1999 1998 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Xu United States 24 4.4k 1.7k 1.1k 827 706 38 5.9k
Marian L. Waterman United States 44 5.5k 1.2× 1.0k 0.6× 1.1k 0.9× 789 1.0× 983 1.4× 75 7.2k
Hung‐Ying Kao United States 36 5.3k 1.2× 1.5k 0.8× 954 0.8× 740 0.9× 527 0.7× 78 6.3k
David M. Lonard United States 38 4.0k 0.9× 2.7k 1.5× 1.4k 1.2× 706 0.9× 726 1.0× 86 6.0k
Kristen Jepsen United States 28 3.3k 0.7× 1.3k 0.7× 769 0.7× 740 0.9× 703 1.0× 50 4.9k
Lisa Garrett United States 25 3.1k 0.7× 874 0.5× 1.3k 1.1× 540 0.7× 503 0.7× 50 5.0k
Régine Losson France 47 6.1k 1.4× 2.1k 1.2× 714 0.6× 1.1k 1.3× 447 0.6× 84 7.2k
Douglas S. Darling United States 41 4.1k 0.9× 1.6k 0.9× 1.6k 1.4× 564 0.7× 1.4k 2.0× 90 6.5k
Rikiro Fukunaga Japan 32 3.3k 0.8× 831 0.5× 1.3k 1.2× 1.7k 2.0× 440 0.6× 71 5.7k
Silvia Cereghini France 38 3.9k 0.9× 1.7k 1.0× 626 0.6× 356 0.4× 472 0.7× 74 5.8k
Shaun M. Cowley United Kingdom 28 4.5k 1.0× 1.1k 0.6× 1.0k 0.9× 425 0.5× 434 0.6× 46 5.5k

Countries citing papers authored by Lan Xu

Since Specialization
Citations

This map shows the geographic impact of Lan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Xu more than expected).

Fields of papers citing papers by Lan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Xu. The network helps show where Lan Xu may publish in the future.

Co-authorship network of co-authors of Lan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Xu. A scholar is included among the top collaborators of Lan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Xu. Lan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xu, Yuxiang Wang, Xi Zhang, et al.. (2023). Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. Signal Transduction and Targeted Therapy. 8(1). 153–153. 6 indexed citations
2.
Wang, Yi, et al.. (2022). Targeting PI3Kα overcomes resistance to KRasG12C inhibitors mediated by activation of EGFR and/or IGF1R. Acta Pharmacologica Sinica. 44(5). 1083–1094. 14 indexed citations
3.
Chen, Ziqi, Yi Wang, Xi Zhang, et al.. (2021). Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kα against B cell lymphoma. Cancer Letters. 524. 206–218. 11 indexed citations
4.
Li, Qi, Niraj K. Nirala, Yingchao Nie, et al.. (2018). Ingestion of Food Particles Regulates the Mechanosensing Misshapen-Yorkie Pathway in Drosophila Intestinal Growth. Developmental Cell. 45(4). 433–449.e6. 38 indexed citations
5.
Wang, Wenbo, Miao Qu, Lan Xu, et al.. (2016). Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways. Journal of Molecular Medicine. 94(10). 1181–1194. 63 indexed citations
6.
Chen, Xiaochu & Lan Xu. (2015). Genome-Wide RNAi Screening to Dissect the TGF-β Signal Transduction Pathway. Methods in molecular biology. 1344. 365–377. 1 indexed citations
7.
Li, Qi, Shuangxi Li, Sebastian Mana‐Capelli, et al.. (2014). The Conserved Misshapen-Warts-Yorkie Pathway Acts in Enteroblasts to Regulate Intestinal Stem Cells in Drosophila. Developmental Cell. 31(3). 291–304. 116 indexed citations
8.
Su, Zhenyi, Lan Xu, Jinbo Cheng, et al.. (2011). The calcineurin B subunit induces TNF-related apoptosis-inducing ligand (TRAIL) expression via CD11b–NF-κB pathway in RAW264.7 macrophages. Biochemical and Biophysical Research Communications. 417(2). 777–783. 13 indexed citations
9.
Chen, Xiaochu & Lan Xu. (2011). Mechanism and Regulation of Nucleocytoplasmic Trafficking of Smad. Cell & Bioscience. 1(1). 40–40. 35 indexed citations
10.
Li, Bin, Lan Xu, Wen Xu, et al.. (2010). A whole-mechanical method to establish human embryonic stem cell line HN4 from discarded embryos. Cytotechnology. 62(6). 509–518. 9 indexed citations
11.
Zhang, Lijuan, He Huang, Luyao Deng, et al.. (2008). TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology. 252(1-3). 49–55. 19 indexed citations
12.
Yao, Xiaohao, et al.. (2008). Preferential Utilization of Imp7/8 in Nuclear Import of Smads. Journal of Biological Chemistry. 283(33). 22867–22874. 65 indexed citations
13.
Rud, Jonathan, et al.. (2005). Nuclear Targeting of Transforming Growth Factor-β-activated Smad Complexes. Journal of Biological Chemistry. 280(22). 21329–21336. 53 indexed citations
14.
Xu, Lan & Joan Massagué. (2004). Nucleocytoplasmic shuttling of signal transducers. Nature Reviews Molecular Cell Biology. 5(3). 209–219. 219 indexed citations
15.
Xu, Lan, et al.. (2003). Distinct Domain Utilization by Smad3 and Smad4 for Nucleoporin Interaction and Nuclear Import. Journal of Biological Chemistry. 278(43). 42569–42577. 96 indexed citations
17.
Xu, Lan, Ye‐Guang Chen, & Joan Massagué. (2000). The nuclear import function of Smad2 is masked by SARA and unmasked by TGFb-dependent phosphorylation. Nature Cell Biology. 2(8). 559–562. 130 indexed citations
18.
Xu, Lan, Christopher K. Glass, & Michael G. Rosenfeld. (1999). Coactivator and corepressor complexes in nuclear receptor function. Current Opinion in Genetics & Development. 9(2). 140–147. 784 indexed citations breakdown →
19.
Xu, Lan, Jeremy S. Dasen, Sarah E. Flynn, et al.. (1998). Signal-specific co-activator domain requirements for Pit-1 activation. Nature. 395(6699). 301–306. 246 indexed citations
20.
Kosaki, Atsushi, Tahir S Pillay, Lan Xu, & Nicholas J. G. Webster. (1995). The B Isoform of the Insulin Receptor Signals More Efficiently Than the A Isoform in HepG2 Cells. Journal of Biological Chemistry. 270(35). 20816–20823. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026